Page results
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
This booklet is designed for teenagers and young people. It explains what you can expect when you finish your treatment for Hodgkin lymphoma.
-
Myeloproliferative neoplasms (MPN) are disorders that affect how the body produces red blood cells, white blood cells, and platelets.
-
Anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.
-
The Inherited White Matter Disorders (IWMD) Diagnostic and Management Service is a formally commissioned highly specialised service. There are seven centres across England. There are three centres…
-
The Royal National ENT and Eastman Dental Hospitals is one of the UK's largest hospitals for ENT hospital surgery and Audiovestibular Medicine and provides a wide range of services, from…
-
Please see below for information relating to various vaccination services offered at UCLH. To check which vaccinations you’ve had in the past, view your GP record using your NHS account or…
-
This page answers common questions about cryotherapy.
-
National Patient Safety Alert Babies and young children (under five years) or children with additional needs, vulnerable adults and pets can suffer serious injury if they ingest coin/button batteries…
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment